drugset / Trial / NCT01247064

Hypertonic Saline for Acute Bronchiolitis

NCT01247064

Phase 4 Completed 62 enrolled Children's Hospital of Philadelphia
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether nebulized 3% hypertonic saline (HS) improves respiratory distress in children 2-23 months presenting to the emergency department (ED) with acute bronchiolitis with persistent respiratory distress after initial therapy with a trial of nebulized albuterol.

Timeline

Start
2010-10
Primary completion
2011-12
Completion
2011-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Hypertonic saline Unknown 3 % Inhaled
Subject Hypertonic saline Unknown 4 ml Inhaled

Indications